Biotech Industry Intelligence

AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans

AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans

Published

on

AstraZeneca has added more details on how it will use its $15 billion budget to expand in China — and the UK pharma is betting on cell therapy.

AstraZeneca​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version